deferred share

It would be the last, deferred sharing with his dear Rehbehkah.

Deferred shares obviate a reduction of capital, and the rights attaching to them are negligible.

A replacement instrument has been created as Core Capital Deferred Shares.

Bonuses to chief executives and executive directors were paid in deferred shares and there was a £2,000 limit on cash awards.

Spyker agreed to pay $74 million in cash and $326 million in deferred shares for the car-maker.

Jan 26 - Spyker clinches a last-minute deal to buy Saab for $400m, $74m in cash, the rest in deferred shares.

The ordinary shares are the equity provided to management and therefore rank last in priority (subject only to the deferred shares, which are often used for the purpose of a ratchet mechanism).

It will be necessary to create deferred shares only if there is a ratchet (see below) in the Articles, where conversion, as opposed to redemption, is essential to the operation of the ratchet.

Jan 26, 2010 - Niche Dutch sportscar maker Spyker buys Saab from General Motors for $400m - $74m in cash, the rest in deferred shares.

The pay included a $1.25 million salary, a $2.2 million bonus that Sabia converted to deferred share units, a long-term incentive payout of $3 million and other compensation, the filing shows.

Capital -£200,000 in 40,000 shares of £5 each; 13,332 fully paid deferred shares will be allotted to the vendors leaving 26,668 shares of £5 each which are now offered for subscription.

In governance terms, the West Brom is covering itself by pledging that no dividends will be paid if the society makes a loss, and that a quarter of the losses will be offset against the new Profit Participating Deferred Shares.

Small numbers at the top are paid obscene sums of money...but they do pay income tax on those bonuses and much of those bonuses are in deferred shares that they can sell over time...and if they are making a lot of money for their employer then why not.

According to the New York Times, since 1997 she has been on the Board of Bristol-Myers Squibb, and "received $244,5000 in compensation for 2010" and "1.4 million in deferred share units" Her research at Harvard has been partially funded by a three-year contract with Merck, "the company that makes Fosamax".